The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment

Fecha de inicio: 1 de junio de 2012

Inclusion Criteria: Aged 18 - 34 years Body mass index between 18 and 29 kg/m2 Stable body weight for at least 3 months Normal early menstrual cycle follicular phase serum FSH concentration Serum anti-Mullerian hormone (AMH) > 40pmol/L No more than one previous IVF treatment cycle Both ovaries intact Exclusion Criteria: History of any medical, psychological or other condition, or use of any medications, including over-the-counter products, which, in the opinion of the investigators, would either interfere with the study or potentially cause harm to the volunteer Without access at home to a telephone, or other factor likely to interfere with ability to participate reliably in the study Treatment with an investigational drug within the preceding 2 months Donated blood during the preceding 3 months or intention to do so before the end of the study Previous poor response to IVF treatment